Mayo Clinic in Rochester, Minn., has announced it will receive funding through the Biomarkers of Gut Function and Health program, according to a news release.
The funding will go to William Faubion, MD, a Mayo Clinic gastroenterologist, who will continue to pursue a research project titled "Gut Permeability in Environmental Enteropathy."
The goal of the Biomarkers of Gut Function grant program, which is operated within the Grand Challenges in Global Health initiative, is to identify and validate biomarkers that can assess gut function and guide new ways to improve the health and development of children in the developing world, according to the release.
Related Articles on Gastroenterology:
Gastroenterologist Dr. Mark Feldman Honored By ACG and ACP
Gastroenterologist on the Move: Dr. Aruna K. Jayaraman Joins CA's Sutter Pacific Medical Foundation
70 of the Ambulatory Surgery Centers That Opened in the U.S. in 2012